global
perspect
gastric
cancer
gc
fourth
common
malign
tumor
second
caus
cancerrel
death
account
estim
new
case
death
past
sever
decad
intens
effort
made
identifi
tool
improv
prognost
gastric
cancer
well
consid
promis
novel
biomark
gc
howev
except
cancer
stage
upon
adjuv
treatment
depend
definit
predict
factor
prognosi
gc
rel
scarc
thu
find
new
prognost
tool
biomark
accur
diagnosi
gc
vital
import
improv
therapeut
effect
prolong
surviv
patient
eukaryot
initi
factor
subunit
multisubunit
complex
play
import
role
translat
initi
although
role
complex
defin
shutoff
experi
schizosaccharomyc
pomb
show
longterm
period
essenti
viabil
translat
system
indic
mammalian
cell
neg
regul
translat
play
import
role
human
cancer
studi
marchion
et
al
show
f
subunit
repres
promis
candid
molecul
use
biotherapeut
applic
previou
studi
identifi
protein
involv
apoptot
signal
neg
regul
translat
also
demonstr
express
significantli
decreas
mani
human
cancer
thu
play
import
role
human
cancer
shi
et
al
report
downregul
sever
human
tumor
overexpress
inhibit
cell
prolifer
melanoma
pancreat
cancer
cell
recent
studi
higaredamendoza
also
show
essenti
cell
prolifer
absenc
induc
cell
enter
apoptosi
togeth
previou
find
suggest
may
involv
regul
cell
growth
prolifer
contribut
tumorigenesi
howev
role
gc
remain
unclear
thu
order
shed
light
express
gc
correl
express
result
clinicopatholog
characterist
prognosi
gc
patient
conduct
experi
character
local
immunohistochemistri
aim
find
new
prognost
marker
gc
new
diagnosi
treatment
strategi
review
surgic
specimen
second
hospit
shandong
univers
novemb
march
yield
case
gc
patient
undergon
cur
surgeri
mean
age
patient
year
rang
year
median
followup
period
month
rang
month
tnm
stage
tumor
assess
accord
ed
tnm
classif
gc
overexpress
detect
postop
fluoresc
situ
hybrid
examin
patient
underw
radiotherapi
chemotherapi
oper
immunohistochem
stain
paraffinembed
tissu
section
obtain
case
radic
resect
gc
fragment
fix
neutral
formol
case
review
pathologist
confirm
malign
investig
approv
ethic
committe
medic
faculti
written
inform
consent
obtain
patient
polyclon
antibodi
bought
abcom
cambridg
uk
paraffinembed
tissu
block
section
mm
slice
place
anti
slide
dewax
hydrat
slide
rins
phosphatebuff
salin
pb
block
min
hydrogen
peroxid
depriv
endogen
peroxidas
activ
antigen
retriev
use
microwav
specimen
incub
anti
mab
dilut
pb
hour
section
wash
min
pb
incub
reagent
mouserabbit
hypersensit
twostep
immunohistochem
kit
beij
fir
jinqiao
beij
china
total
min
humid
chamber
section
wash
min
pb
follow
addit
diaminobenzidin
chromogen
min
strictli
control
microscop
antibodi
optim
use
posit
control
tissu
accord
manufactur
instruct
neg
control
primari
antibodi
replac
pb
remain
procedur
perform
parallel
specimen
slide
score
blind
fashion
two
pathologist
accord
manufactur
recommend
criteria
magnif
overal
percentag
posit
cell
immunostain
section
determin
accord
pattern
intracellular
local
extent
pattern
immunostain
within
tissu
section
determin
percentag
cell
cytoplasm
stain
immunostain
read
semiquantit
manner
three
visual
field
examin
randomli
rate
posit
cell
divid
less
score
score
score
score
score
stain
intens
divid
three
grade
stain
score
slightli
yellowish
score
brownish
yellow
score
dark
brown
score
multipl
two
grade
follow
score
score
score
score
intens
score
design
low
express
design
high
express
differ
group
analyz
use
student
ttest
continu
variabl
test
fisher
exact
test
proport
overal
surviv
rate
estim
kaplanmei
method
univari
analys
cox
proport
hazard
regress
model
also
perform
assess
prognost
valu
nucleolin
express
clinicopatholog
featur
util
sa
softwar
system
statist
analysi
case
men
women
accept
radic
oper
gc
includ
primari
recurr
gc
patient
patholog
case
adenocarcinoma
cover
well
differenti
moder
differenti
low
differenti
signetr
cell
carcinoma
specimen
case
demonstr
immunohistochem
stain
show
cytoplasm
stain
pattern
gc
figur
b
anct
figur
tissu
immunoscor
calcul
presenc
deposit
tumor
gland
cytoplasm
stain
posit
rate
high
express
gc
anct
tissu
respect
associ
level
clinicopatholog
featur
gc
also
assess
tabl
low
express
gc
significantli
associ
advanc
tumor
stage
p
likelihood
recurr
p
howev
express
significantli
correl
sex
p
age
p
tumor
differenti
p
tumor
size
p
stage
case
high
stain
densitometri
valu
higher
case
stage
iii
p
furthermor
overal
densitometr
analysi
immunostain
reveal
downregul
protein
express
vari
significantli
primari
recurr
tumor
p
prognost
effect
surviv
rate
gc
patient
investig
compar
surviv
rate
patient
high
low
level
protein
express
tumor
use
kaplanmei
surviv
curv
logrank
test
univari
cox
regress
analysi
show
clinic
variabl
includ
tumor
size
logrank
p
figur
tumor
recurr
logrank
p
figur
express
logrank
p
figur
significantli
associ
overal
surviv
tabl
data
indic
high
express
protein
signific
prognost
factor
better
surviv
gc
patient
furthermor
multivari
cox
regress
analys
show
express
independ
predictor
overal
surviv
patient
gc
although
incid
mortal
rate
gc
fallen
past
sever
decad
gc
still
fourth
common
cancer
second
lead
caus
cancerrel
death
world
disappointingli
littl
improv
achiev
within
past
sever
decad
despit
advanc
tumor
diagnosi
treatment
given
high
failur
rate
convent
treatment
strategi
mani
cancerrel
molecul
character
goal
develop
novel
anticanc
strategi
anoth
subunit
whose
function
wellknown
previou
studi
demonstr
overexpress
inhibit
cell
prolifer
induc
apoptosi
melanoma
pancreat
cancer
cell
suggest
downregul
involv
tumorigenesi
mani
type
cancer
howev
larg
sampl
report
express
clinic
signific
human
gc
progress
prognosi
studi
investig
express
gc
well
correl
clinicopatholog
featur
prognosi
data
studi
show
level
protein
significantli
lower
gc
tissu
compar
pair
anct
addit
decreas
express
protein
significantli
relat
advanc
tumor
stage
p
likelihood
recurr
p
statist
signific
relationship
found
level
sex
p
age
p
tumor
differenti
p
tumor
size
p
kaplanmei
surviv
curv
show
patient
low
express
significantli
poorer
surviv
compar
patient
high
express
furthermor
multivari
cox
regress
analys
show
tumor
size
p
recurr
p
express
p
prognost
predictor
human
gc
resect
base
result
propos
bold
hypothesi
preoper
determin
express
may
use
predict
therapeut
effect
postop
surviv
human
gc
drawback
present
studi
lack
investig
molecular
cellular
level
gc
therefor
studi
perform
concret
evid
support
correl
express
malign
degre
gc
summari
downregul
gc
ultim
may
play
import
role
progress
recurr
gc
howev
specif
regulatori
mechan
remain
studi
provid
potenti
target
treatment
gc
anct
adjac
noncancer
tissu
eukaryot
initi
factor
gc
gastric
carcinoma
pb
phosphatebuff
salin
tnm
tumor
node
metastasi
author
declar
compet
interest
gl
design
studi
gave
conceptu
advic
cs
perform
experi
bl
collect
data
perform
followup
work
patient
nw
analyz
data
wrote
manuscript
author
read
approv
final
manuscript
